Loading...
Loading...
Among the 7 tracked institutional investors we monitor, PHAT (PHATHOM PHARMACEUTICALS INC) is held with a combined value of $171.62M across 13,879,989 shares. The largest holder is VANGUARD GROUP INC with a position worth $52.71M (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 4 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$171.62M
Total Shares Held
13,879,989
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $52.71M | 0.00% | New |
| 2 | BlackRock, Inc. | $45.13M | 0.00% | +14.2% |
| 3 | MILLENNIUM MANAGEMENT LLC | $44.69M | 0.02% | +93.2% |
| 4 | STATE STREET CORP | $15.41M | 0.00% | +20.6% |
| 5 | CITADEL ADVISORS LLC | $10.20M | 0.00% | +123.8% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | $3.40M | 0.01% | New |
| 7 | FMR LLC | $78.04K | 0.00% | -2.2% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of PHAT with a position worth $52.71M, representing 0.00% of their portfolio. In total, 7 institutional investors hold PHAT with a combined value of $171.62M.
In the most recent quarter, 2 funds opened a new position in PHAT. Additionally, 4 increased their holdings and 1 reduced their positions.
Institutional investors hold $171.62M worth of PHAT stock across 7 positions. The largest institutional holder is VANGUARD GROUP INC with $52.71M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For PHAT, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their PHAT positions.